2m 2m 2m 2m 2m 2m 2m
Eli Lilly & Co (LLY)
NYSE
$1,147.59-$2.26 (-0.20%)
Price as of Oct 02, 2026 3:09 PM EDT- $1.0TMarket Cap
- 41.14%1-Year Change
- Drug Manufacturers - GeneralIndustry
Eli Lilly & Co (LLY)
$1,147.59-$2.26 (-0.20%)
LLY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1,149.85 | ||
Change | -$7.23 (-0.62%) | ||
Open | $1,155.00 | ||
High | $1,158.72 | ||
Low | $1,139.85 | ||
Previous Close | $1,157.08 | ||
Volume | 2,174,701 | ||
30-Day Average Volume | 2,303,017 | ||
1-Week Change | -2.71% | ||
1-Month Change | -0.88% | ||
1-Year Change | 41.14% | ||
3-Year Change | 118.53% | ||
5-Year Change | 424.08% | ||
Fundamentals | |||
Shares Outstanding | 891.4M | ||
Total Assets | $142.3B | ||
Market Cap | $1.0T | ||
Enterprise Value | $1.1T | ||
Period: QTR TTM FY | |||
Revenue | $23.0B | ||
Net Income | $7.1B | ||
Free Cash Flow | $10.7B | ||
EBIT | $9.2B | ||
EBITDA | $9.8B | ||
Net Working Capital | $16.9B | ||
EPS | $7.94 | ||
Enterprise Value/EBITDA | 109 | ||
Enterprise Value/Revenue | 47 | ||
P/B | 30 | ||
P/E | 145 | ||
PEG | -37 | ||
Price/Free Cash Flow | 96 | ||
Price/Operating Cash Flow | 96 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.60% | ||
Trailing Annual Dividend Yield | 0.58% | ||
Ex-Dividend Date | 08/14/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield